When Does a South African Endowment Make Sense?

The question is not whether an endowment is a good investment in isolation. It is whether this policy is a better way for you to hold an investment than the alternatives. A sound fund can be held through an unsuitable wrapper, and a suitable wrapper does not make a weak investment sound.

In this article

Separate the investment from the contract

An investment-linked endowment is a policy issued by an insurer, with investments supporting its value. The policyholder owns the contractual rights, rather than personally holding each underlying investment. The insurer, investment manager and administrator need not be the same entity. Read the actual documents identifying each role.

For example, the Allan Gray Endowment brochure distinguishes the owner, life assured and beneficiaries. Its underlying funds determine investment exposure. The policy is not a promise that capital will be repaid at a particular date or that a certain return will be earned.

Before comparing tax, ask whether the two proposals contain genuinely comparable assets. A lower tax rate cannot explain a difference caused by one portfolio holding more shares, taking more credit risk or charging different fund fees. Compare the container and its contents separately.

What does the 30% tax rate actually describe?

For an individual whose investment is allocated to the insurer's individual policyholder fund, taxable income is generally taxed within that fund at 30%. The effective CGT rate on net capital gains in that fund is generally 12%: 40% of the net capital gain is included in taxable income and taxed at 30%. Those are not taxes on the capital you contribute, and they are not one flat rate on every type of return.

The SARS rates guide, section 1.3.1 describes the insurer fund system. Current Allan Gray product information explains the 30% income treatment; its offshore endowment brochure, printed page 2 states the individual-policyholder 12% CGT calculation. These sources do not make the same treatment universal for every company, trust or foreign resident.

Direct personal investment has its own tax allowances. For the 2027 tax year, SARS lists a South African-source interest exemption of R23,800 for people younger than 65 and R34,500 from age 65. It separately lists a R50,000 annual capital-gain-or-loss exclusion for individuals and special trusts. Those personal allowances are not an extra allowance you deduct from the insurer's quoted policy tax. SARS interest exemptions; SARS CGT exclusions.

Income composition therefore matters. A portfolio generating taxable interest presents a different comparison from one with mainly unrealised capital gains or dividends. The timing of disposals matters too. A statement comparing maximum tax rates is not a calculation of the tax that either actual portfolio will incur.

The same marginal rate can produce a very different tax comparison

Consider invented receipts of R100,000 of South African-source interest for a completed hypothetical tax year. Assume an individual younger than 65 has enough other taxable income that all additional taxable interest falls within the 41% bracket, without crossing a bracket. Compare that with R100,000 of taxable interest attributed within an individual-policyholder fund at 30%.

There are no fees, deductions, capital gains or dividends in this isolated example. The receipt is an assumed amount, not a forecast of investment yield.

The person's marginal rate has not changed, but the difference has fallen by R9,758. That is 41% of the exemption now available to the direct holding.

Neither row establishes that an endowment should be bought. Costs have still to be compared. An additional quoted charge of R5,000 would be material against either difference, especially the second, and its tax treatment must also be established. Access restrictions and succession arrangements have no price in this table. The example cannot turn them into free benefits or costs of zero.

A lower personal tax rate, unused allowances, a different mix of returns or fewer taxable realisations can weaken the tax case. Conversely, exhausted allowances and substantial taxable returns can strengthen it. A comparison should show the reason, rather than simply display the investor's highest tax bracket.

The example above states the inputs and arithmetic. It contains no future balances, growth assumption or break-even date.

Five years does not mean no access, or unrestricted access

A restriction period is an access constraint, not a five-year guarantee. The Allan Gray local brochure describes one limited withdrawal during the initial five years, with further conditions on the amount. For this policy, contributions exceeding 120% of the higher total paid in either of the previous two policy years can start or extend a five-year restriction on the entire policy. Check the provider's application to your contribution history.

Do not translate that into a universal statement that every plan allows only one transaction in total. Product designs, underlying policies and any loan facility must be checked separately.

A practical test is to put a dated obligation beside the policy terms. If money may be needed for a property transfer, business liability or family support, ask how much could actually be paid on that date. A balance on a statement is not proof of accessible cash. If access depends on using a limited withdrawal, establish what flexibility remains afterwards.

The same check is needed for new contributions. Before adding a large amount to an older policy, request the restriction-period calculation in writing. An existing policy's age does not prove that all future contributions will be unrestricted.

A beneficiary payment is not the same as an estate-duty exemption

The local brochure distinguishes a beneficiary who can take ownership from one who receives proceeds. It also explains what happens where no nominated beneficiary can receive the benefit. The identity of the owner and life assured can change the route.

Those details may simplify administration. They do not justify the blanket claim that an endowment is outside the estate for every purpose. SARS expressly notes that estate duty attributable to a policy paid directly to a beneficiary can be payable by that beneficiary. SARS estate-duty guidance, “Who is liable?”.

Ask four separate questions: who receives the benefit, whether the policy continues, what tax arises and what charges apply. Then ask when payment can realistically occur after the required documents and checks. A provider's description of payment without waiting for the estate to be wound up is not a guaranteed number of days.

Avoid relying on a beneficiary entry made years earlier. A changed family, deceased nominee or intended beneficiary living abroad calls for document review, not an assumption that the original arrangement still achieves the purpose.

The cost comparison should survive a retain-and-improve alternative

Request total charges at the same valuation and on the same assumptions: underlying investment management, policy/platform administration, advice, discretionary management where relevant and transaction or exit costs. Establish whether VAT and underlying charges are already included. An apparent extra fee can be double counting; an apparently cheap wrapper can omit another layer.

If existing investments must be sold to fund the policy, assess that transaction separately. A lower future tax rate does not undo an immediate disposal or an exit charge. Do not assume an in-specie transfer preserves the same tax treatment without checking the legal transaction.

There is a reasonable case for retaining a direct holding when its access, costs and unused personal allowances fit the purpose. There is also a reasonable case for a policy where its documented tax and beneficiary arrangements solve a real problem at an acceptable cost. Neither case requires declaring one structure universally superior.

An existing endowment presents a further question. Restrictions already elapsed, embedded tax, termination consequences and original contractual rights can make retaining it different from buying the same product today. A disappointing investment fund does not by itself prove that the wrapper should be surrendered.

What should the decision record contain?

Record the money's purpose, likely access dates, investor classification, underlying exposure, expected types of taxable receipts, unused personal allowances and all quoted charges. Add the consequence of funding or exiting the policy, the beneficiary route, and the strongest simpler alternative.

ClearGauge's judgement is that a wrapper should earn its place twice: during the owner's life, through workable costs and access; and at death, through arrangements that actually fit the intended beneficiaries. A tax-rate comparison answers only part of the first test.

For connected questions, read RA or TFSA, investment ownership and the offshore-wrapper comparison. A product choice involving several household decisions may warrant a bounded Financial Clarity Review.

ClearGauge offers paid Financial Clarity Reviews and has a commercial interest in review engagements. This framework can also support retaining the existing arrangement or using another adviser.

Sources and scope

Researched 7 September 2026 for a South African resident individual. Personal allowances use the 2027 tax-year tables. Provider documents describe specified policies, not every endowment; the offshore brochure used for the insurer CGT calculation is effective 18 August 2026. The SARS guide supplies the fund-tax framework, with current provider corroboration for the rates discussed. Product terms, tax rules and personal circumstances need rechecking before action.

The examples are current-tax arithmetic, not predicted product benefits. No investment, transfer or surrender has been recommended for a particular person. Company/trust policyholder treatment, emigration and disputed tax classifications need their own advice.